Literature DB >> 11074210

Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects.

A Festa1, R D'Agostino, P Rautaharju, L Mykkänen, S M Haffner.   

Abstract

A prolonged QT interval has been identified as a risk factor for cardiovascular disease; however, knowledge about etiologic factors is limited. We studied determinants of QT interval duration in the Insulin Resistance Atherosclerosis Study, a large, triethnic population (n = 1,577) with varying degrees of glucose tolerance. In particular, we sought to investigate the relation of QT interval with blood pressure (BP), left ventricular (LV) mass, estimated using electrocardiographic criteria, and insulin sensitivity, directly measured by a frequently sampled intravenous glucose tolerance test. QT interval was measured electronically on electrocardiograms at rest and corrected for heart rate using standard equations. The QT interval was related to various components of the insulin resistance syndrome, including BP and insulin sensitivity. Multivariate analyses showed that BP and LV mass were the main determinants of the QT interval in diabetic and nondiabetic subjects. Additionally, prevalent coronary artery disease was related to the QT interval in subjects with newly diagnosed diabetes. In conclusion, we found that BP and LV mass were the strongest and most consistent determinants of the QT interval in nondiabetic and diabetic subjects. Additional factors potentially contributing to QT interval prolongation in diabetic patients include insulin sensitivity and prevalent coronary artery disease.

Entities:  

Mesh:

Year:  2000        PMID: 11074210     DOI: 10.1016/s0002-9149(00)01170-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  22 in total

Review 1.  The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence.

Authors:  C Nordin
Journal:  Diabetologia       Date:  2010-04-21       Impact factor: 10.122

2.  The impact of metabolic control and QTc prolongation on all-cause mortality in patients with type 2 diabetes and foot ulcers.

Authors:  K Fagher; M Löndahl
Journal:  Diabetologia       Date:  2013-02-12       Impact factor: 10.122

3.  Gender-specific effect of metabolic syndrome on rate adjusted QT interval in middle-aged participants of an atherosclerosis prevention program.

Authors:  Bernhard Strohmer; Christiana Schernthaner; Bernhard Iglseder; Bernhard Paulweber; Maximilian Pichler
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 4.  QT interval, cardiovascular risk factors and risk of death in diabetes.

Authors:  M Veglio; A Chinaglia; P Cavallo-Perin
Journal:  J Endocrinol Invest       Date:  2004-02       Impact factor: 4.256

5.  Association of increased QTc interval with the cardiometabolic syndrome.

Authors:  Andrew Grandinetti; Dominic C Chow; Marc Miyasaki; Phillip Low
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-04       Impact factor: 3.738

6.  QT Interval prolongation and dispersion: Epidemiology and clinical correlates in subjects with newly diagnosed systemic hypertension in Nigeria.

Authors:  Adeseye A Akintunde; Adebayo T Oyedeji; Oluranti B Familoni; Olugbenga E Ayodele; Oladimeji G Opadijo
Journal:  J Cardiovasc Dis Res       Date:  2012-10

7.  Prevalence and risk factors of prolonged QTc interval among Chinese patients with type 2 diabetes.

Authors:  Xiang Li; Hui Ren; Zhang-rong Xu; Yan-jun Liu; Xiao-pin Yang; Jian-qin Liu
Journal:  Exp Diabetes Res       Date:  2012-12-25

8.  Pharmacometabolomic approach to predict QT prolongation in guinea pigs.

Authors:  Jeonghyeon Park; Keumhan Noh; Hae Won Lee; Mi-sun Lim; Sook Jin Seong; Jeong Ju Seo; Eun-Jung Kim; Wonku Kang; Young-Ran Yoon
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

9.  Cigarette Smoking Is Associated with Prolongation of the QTc Interval Duration in Patients with Type 2 Diabetes Mellitus.

Authors:  Petros Thomakos; Stavros Liatis; Stavroula Kalopita; Ioannis Vlahodimitris; Chryssoula Stathi; Nicholas Katsilambros; Nicholas Tentolouris; Konstantinos Makrilakis
Journal:  Int J Endocrinol       Date:  2013-04-24       Impact factor: 3.257

10.  Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters.

Authors:  Antonio E Pontiroli; Marco Laneri; Annamaria Veronelli; Francesca Frigè; Giancarlo Micheletto; Franco Folli; Gianfranco Adami; Nicola Scopinaro
Journal:  Cardiovasc Diabetol       Date:  2009-07-20       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.